Medtronic Expands Transcatheter Mitral Effort With Acquisition Of Twelve Inc.
This article was originally published in Clinica
The race to develop the best transcatheter mitral replacement valve technology continues to heat-up with Medtronic's $458m acquisition of Twelve, Inc.
You may also be interested in...
The deal gives Medtronic the exclusive right to acquire Half Moon Medical, a start-up developing a mitral valve repair system to compete with Abbott’s MitraClip.
The deal is the fourth major acquisition in the remote monitoring market in the last five weeks after Philips acquired BioTelemetry and Capsule and Hillrom bought Bardy Diagnostics.
New published results demonstrate J&J/Auris’ robotic is safe and effective at diagnosing peripheral pulmonary lesions.